In their classification system, Tervaert et al. 1 divide diabetic nephropathy into four classes based on the presence of what they consider to be increasingly serious glomerular lesions ().The ...
Diabetic nephropathy is the leading cause of kidney disease in patients starting renal replacement therapy and affects ~40% of type 1 and type 2 diabetic patients. It increases the risk of death ...
接《对痛风,我们了解多少?(二)》血尿酸不只是引发痛风,还可以损伤其他脏器。而其中最常见也最重要的是肾脏。尿酸或尿酸结晶沉积可引起三种不同的肾脏疾病:急性尿酸性肾病慢性尿酸盐肾病尿酸性肾结石除此外,还有独特的肾脏疾病,它的重要表现形式就是血尿酸偏高。
Table 1. Diabetic Nephropathy Stages: Cutoff Values of Urine Albumin for Diagnosis and Main Clinical Characteristics Stages Albuminuria cutoff values (ref. 14) Clinical characteristics (ref. no.) ...
We report the case of a woman presenting with uremic symptoms related to obstructive nephropathy from malacoplakia involving both ureters and the bladder. This case report illustrates malacoplakia ...
All diabetics are prone to kidney damage. However, the chances of developing diabetic nephropathy depends on a number of factors. Some diabetics may suffer from kidney damage right at the time of ...
The global IgA Nephropathy Disease Treatment Market is at the forefront of addressing the growing burden of renal diseases worldwide. With a projected value surpassing USD 485 million by 2028, the ...
IgA nephropathy is the most common primary glomerulonephritis and contributes to kidney failure. Growing evidence exists that the overactivation of the lectin pathway contributes to the pathogenesis ...
IgA nephropathy, also known as Berger’s disease, is a progressive, autoimmune, chronic kidney disease that predominantly affects adults between the ages of 20 and 40. It is characterized by the ...
IgA nephropathy (IgAN) is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their surface. A recent Phase 2 trial revealed that felzartamab, an ...
"These data further our understanding of the role of CD38 + antibody secreting cells in IgA nephropathy pathogenesis," said ...
SAN DIEGO -- A novel drug significantly reduced IgA nephropathy-related proteinuria, according to interim findings of the ...